JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2001; 38:1023-1027
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meisel, C.
Right arrow Articles by Stangl, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meisel, C.
Right arrow Articles by Stangl, K.

CLINICAL STUDY

Role of Kozak sequence polymorphism of platelet glycoprotein Ib{alpha} as a risk factor for coronary artery disease and catheter interventions

Christian Meisel, MD*, Vahid Afshar-Kharghan, MD{ddagger}, Ingolf Cascorbi, MD, PhD*, Michael Laule, MD{dagger}, Verena Stangl, MD{dagger}, Stefan B. Felix, MD{dagger}, Gert Baumann, MD{dagger}, José A. López, MD{ddagger}, Ivar Roots, MD* and Karl Stangl, MD{dagger}

* Institute of Clinical Pharmacology, Berlin, Germany
{dagger} Department of Cardiology, Charité University Medical Center, Campus Mitte, Humboldt University of Berlin, Berlin, Germany
{ddagger} Departments of Medicine and Molecular and Human Genetics, Baylor College of Medicine and Veterans Affairs Medical Center, Houston, Texas, USA

Manuscript received October 12, 2000; revised manuscript received April 16, 2001, accepted June 14, 2001.

Reprint requests and correspondence: Dr. Karl Stangl, Medizinische Klinik und Poliklinik, Kardiologie, Angiologie und Pneumologie, Universitätsklinikum Charité, Campus Mitte, Humboldt-Universität zu Berlin, D-10098 Berlin, Germany
karl.stangl{at}charite.de

OBJECTIVES

We sought to determine the role of the –5T/C polymorphism of the platelet glycoprotein (GP) Ib{alpha} as a potential risk factor for coronary artery disease (CAD) and adverse events complicating a coronary catheter intervention.

BACKGROUND

The platelet GP Ib-IX-V receptor complex plays a crucial role in arterial thrombus formation. The –5T/C polymorphism of GP Ib{alpha} is associated with increased receptor density.

METHODS

We genotyped 1,000 patients with angiographically confirmed CAD, as well as 1,000 age- and gender-matched control subjects, for this polymorphism by polymerase chain reaction/restriction fragment length polymorphism. Among the patients with CAD, 269 underwent percutaneous transluminal coronary angioplasty (PTCA), 103 underwent directional coronary atherectomy and 278 underwent stenting. This intervention group was followed for a 30-day composite end point of target vessel revascularization, myocardial infarction or death.

RESULTS

Carriers of the –5C allele were significantly over-represented in the group of patients developing acute coronary syndromes (relative risk [RR] 1.43, 95% confidence interval [CI] 1.05 to 1.95, p = 0.02). The –5C allele furthermore predicted an increased risk for developing complications after PTCA (RR 3.75, 95% CI 1.15 to 12.27, p = 0.029).

CONCLUSIONS

The –5C allele of the GP Ib{alpha} Kozak polymorphism may represent a risk factor in clinical conditions in which thrombosis plays an important role, such as in acute coronary syndromes and in complications after PTCA.

Abbreviations and Acronyms
  CAD = coronary artery disease
  CI = confidence interval
  CRP = C-reactive protein
  DCA = directional coronary atherectomy
  GP = glycoprotein
  PAI-1 = plasminogen activator inhibitor-1
  PTCA = percutaneous transluminal coronary angioplasty
  RR = relative risk
  vWF = von Willebrand factor




This article has been cited by other articles:


Home page
BloodHome page
P. F. Bray, T. D. Howard, E. Vittinghoff, D. C. Sane, and D. M. Herrington
Effect of genetic variations in platelet glycoproteins Ib{alpha} and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy
Blood, March 1, 2007; 109(5): 1862 - 1869.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
J. Mikkelsson, M. Perola, and P. J. Karhunen
Genetics of Platelet Glycoprotein Receptors: Risk of Thrombotic Events and Pharmacogenetic Implications
Clinical and Applied Thrombosis/Hemostasis, April 1, 2005; 11(2): 113 - 125.
[Abstract] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2001 by the American College of Cardiology Foundation.